{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/QNRX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T08:34:11.687Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":12191,"canonical_name":"Quoin Pharmaceuticals, Ltd.","cik":"0001671502","uei":null,"lei":null,"duns":null,"ticker":"QNRX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":27},"count":27,"timeline":[{"ts":"2026-10-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Quoin Pharmaceuticals Ltd. — 2026-10-14","url_slug":"/sec/cik-0001671502/8-k/0001104659-26-115709","accession_number":"0001104659-26-115709","importance":35},{"ts":"2026-10-07","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Quoin Pharmaceuticals Ltd. — 2026-10-07","url_slug":"/sec/cik-0001671502/schedule-13g-a/0001778253-26-000004","accession_number":"0001778253-26-000004","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Quoin Pharmaceuticals Ltd. — 2026-10-02","url_slug":"/sec/cik-0001671502/def-14a/0001104659-26-113301","accession_number":"0001104659-26-113301","importance":40},{"ts":"2026-09-25","kind":"sec.filing","form_type":"424B3","title":"424B3 — Quoin Pharmaceuticals Ltd. — 2026-09-25","url_slug":"/sec/cik-0001671502/424b3/0001104659-26-111012","accession_number":"0001104659-26-111012","importance":30},{"ts":"2026-09-25","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Quoin Pharmaceuticals Ltd. — 2026-09-25","url_slug":"/sec/cik-0001671502/effect/9999999995-26-003071","accession_number":"9999999995-26-003071","importance":30},{"ts":"2026-09-22","kind":"sec.filing","form_type":"8-K","title":"8-K — Quoin Pharmaceuticals Ltd. — 2026-09-22","url_slug":"/sec/cik-0001671502/8-k/0001104659-26-109639","accession_number":"0001104659-26-109639","importance":35},{"ts":"2026-09-22","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — Quoin Pharmaceuticals Ltd. — 2026-09-22","url_slug":"/sec/cik-0001671502/pre-14a/0001104659-26-109641","accession_number":"0001104659-26-109641","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"S-3","title":"S-3 — Quoin Pharmaceuticals Ltd. — 2026-09-18","url_slug":"/sec/cik-0001671502/s-3/0001104659-26-108970","accession_number":"0001104659-26-108970","importance":30},{"ts":"2026-09-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Quoin Pharmaceuticals Ltd. — 2026-09-10","url_slug":"/sec/cik-0001671502/8-k/0001104659-26-106705","accession_number":"0001104659-26-106705","importance":35},{"ts":"2026-09-10","kind":"sec.filing","form_type":"D","title":"D — Quoin Pharmaceuticals Ltd. — 2026-09-10","url_slug":"/sec/cik-0001671502/d/0001104659-26-106751","accession_number":"0001104659-26-106751","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Quoin Pharmaceuticals, Ltd. — 2026-09-01","url_slug":"/sec/cik-0001671502/4/0001104659-26-104402","accession_number":"0001104659-26-104402","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Quoin Pharmaceuticals, Ltd. — 2026-09-01","url_slug":"/sec/cik-0001671502/4/0001104659-26-104403","accession_number":"0001104659-26-104403","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Quoin Pharmaceuticals, Ltd. — 2026-09-01","url_slug":"/sec/cik-0001671502/4/0001104659-26-104404","accession_number":"0001104659-26-104404","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Quoin Pharmaceuticals, Ltd. — 2026-09-01","url_slug":"/sec/cik-0001671502/4/0001104659-26-104405","accession_number":"0001104659-26-104405","importance":30},{"ts":"2026-08-31","kind":"sec.insider.20490","reporter":"Carter Denise P.","title":"Chief Operating Officer","shares":20490,"price_per_share":4.88,"usd_value":99991,"security_title":"ADSs","importance":15.0999912},{"ts":"2026-08-28","kind":"sec.filing","form_type":"8-K","title":"8-K — Quoin Pharmaceuticals, Ltd. — 2026-08-28","url_slug":"/sec/cik-0001671502/8-k/0001104659-26-102917","accession_number":"0001104659-26-102917","importance":35},{"ts":"2026-08-28","kind":"sec.filing","form_type":"4","title":"4 — Quoin Pharmaceuticals, Ltd. — 2026-08-28","url_slug":"/sec/cik-0001671502/4/0001104659-26-103374","accession_number":"0001104659-26-103374","importance":30},{"ts":"2026-08-20","kind":"sec.filing","form_type":"8-K","title":"8-K — Quoin Pharmaceuticals, Ltd. — 2026-08-20","url_slug":"/sec/cik-0001671502/8-k/0001104659-26-099239","accession_number":"0001104659-26-099239","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Quoin Pharmaceuticals, Ltd. — 2026-08-14","url_slug":"/sec/cik-0001671502/10-q/0001104659-26-097064","accession_number":"0001104659-26-097064","importance":45},{"ts":"2026-08-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Quoin Pharmaceuticals, Ltd. — 2026-08-14","url_slug":"/sec/cik-0001671502/8-k/0001104659-26-097094","accession_number":"0001104659-26-097094","importance":35},{"ts":"2026-07-16","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Quoin Pharmaceuticals, Ltd. — 2026-07-16","url_slug":"/sec/cik-0001671502/def-14a/0001104659-26-084078","accession_number":"0001104659-26-084078","importance":40},{"ts":"2026-07-16","kind":"sec.filing","form_type":"ARS","title":"ARS — Quoin Pharmaceuticals, Ltd. — 2026-07-16","url_slug":"/sec/cik-0001671502/ars/0001104659-26-084081","accession_number":"0001104659-26-084081","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — Quoin Pharmaceuticals, Ltd. — 2026-07-06","url_slug":"/sec/cik-0001671502/pre-14a/0001104659-26-080828","accession_number":"0001104659-26-080828","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"8-K","title":"8-K — Quoin Pharmaceuticals, Ltd. — 2026-06-04","url_slug":"/sec/cik-0001671502/8-k/0001104659-26-070501","accession_number":"0001104659-26-070501","importance":35},{"ts":"2026-06-02","kind":"sec.filing","form_type":"424B3","title":"424B3 — Quoin Pharmaceuticals, Ltd. — 2026-06-02","url_slug":"/sec/cik-0001671502/424b3/0001104659-26-069166","accession_number":"0001104659-26-069166","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Quoin Pharmaceuticals, Ltd. — 2026-05-15","url_slug":"/sec/cik-0001671502/schedule-13g-a/0000919574-26-003240","accession_number":"0000919574-26-003240","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Quoin Pharmaceuticals, Ltd. — 2026-05-15","url_slug":"/sec/cik-0001671502/schedule-13g-a/0001104659-26-062875","accession_number":"0001104659-26-062875","importance":30}]}